Japan-Based clinical ReseArch Network for Diabetes Registry.

Trial Profile

Japan-Based clinical ReseArch Network for Diabetes Registry.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Alogliptin (Primary) ; Antihyperglycaemics
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms J-BRAND Registry
  • Most Recent Events

    • 01 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 18 Nov 2013 Planned end date changed from 30 Jun 2017 to 31 Dec 2017 as reported by University Hospital Medical Information Network - Japan.
    • 09 Nov 2012 Actual initiation Date changed from 1 May 2012 to 1 Sep 2012 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top